These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2488482)

  • 1. [Jaundice caused by rifampicin: 3 cases].
    Taillan B; Chichmanian RM; Fuzibet JG; Vinti H; Taillan F; Dellamonica P; Dujardin P
    Rev Med Interne; 1989; 10(5):409-11. PubMed ID: 2488482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cholestatic hepatitis during treatment with I.N.H. and rifampicin: arguments in favour of the hepatotoxicity of rifampicin (author's transl)].
    Poupon RY; Meyniel D; Petit J; Gustot P; Darnis F
    Ann Med Interne (Paris); 1979; 130(6-7):371-5. PubMed ID: 496138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug-induced hepatitis during a treatment associating isoniazid and rifampicin].
    Jean R; Bonnet H; Pages P; Dumas R; Greze J
    Ann Pediatr (Paris); 1972 Apr; 19(4):307-11. PubMed ID: 5075678
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis.
    Prince MI; Burt AD; Jones DE
    Gut; 2002 Mar; 50(3):436-9. PubMed ID: 11839728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of hepatic function in patients treated with rifampicin].
    Morère P; Bourreille J; Matray F; Stain JP; Métayer P
    Rev Tuberc Pneumol (Paris); 1970; 34(3):403-14. PubMed ID: 5510435
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cholestatic jaundice following rifampicin-troleandomycin: one new case].
    Givaudan JF; Gamby T; Privat Y
    Nouv Presse Med; 1979 Jun; 8(28):2357. PubMed ID: 315057
    [No Abstract]   [Full Text] [Related]  

  • 7. [Icterus caused by rifampicin and isoniazide].
    Haber I; Hubens H; Buyssens N
    Tijdschr Gastroenterol; 1974; 17(3):165-76. PubMed ID: 4454055
    [No Abstract]   [Full Text] [Related]  

  • 8. [Liver tolerance of antitubercular treatment including rifampicin. Study on 214 cases].
    Decroix G; Pujet JC
    Sem Hop; 1973 Jun; 49(30):2219-24. PubMed ID: 4354303
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hepatitis caused by drugs. 3].
    Valerdiz Casasola S; Linares Rodriguez A; Recarte Alvarez J; Sáez L
    Rev Esp Enferm Apar Dig; 1982 Sep; 62(3):246-9. PubMed ID: 6758083
    [No Abstract]   [Full Text] [Related]  

  • 10. [Classification of liver incidents occurring during antitubercular treatments which include rifampicin].
    Blanchon P; Paillas J; Groseille Y; Holler A; Blanchon F
    Ann Med Interne (Paris); 1974 Dec; 125(12):919-22. PubMed ID: 4469954
    [No Abstract]   [Full Text] [Related]  

  • 11. [Icterigenic hepatitis during the treatment with combined isoniazid and rifampicin. Clinical and experimental observations].
    Marche J; Hugues FC; Graisely B; Marche C
    Rev Tuberc Pneumol (Paris); 1971; 35(1):55-76. PubMed ID: 5559725
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fulminating hepatitis caused by administration of isoniazid and rifampicin in a patient under chronic treatment with barbiturates].
    Derveaux L; Demedts M; Fevery J; Gyselen A
    Ned Tijdschr Geneeskd; 1980 Jun; 124(25):1008-12. PubMed ID: 7402377
    [No Abstract]   [Full Text] [Related]  

  • 13. [Amineptine-induced cholestatic hepatitis. 5 cases (author's transl)].
    Bories P; Pomier-Layrargues G; Chotard JP; Citron D; Capron-Chivrac D; Capron JP; Michel H
    Nouv Presse Med; 1980 Dec; 9(48):3689-92. PubMed ID: 7454584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoniazid-rifampicin-induced submassive hepatic necrosis.
    Kasantikul V
    J Med Assoc Thai; 1989 Jan; 72(1):56-8. PubMed ID: 2723568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Jaundice and rifampicin. Critical study].
    Nebout T; Dhumeaux D; Berthelot P
    Nouv Presse Med; 1974 Mar; 3(12):733-6. PubMed ID: 4836507
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hepatotoxicity of rifampicin and isoniazid in the treatment of tuberculous meningitis (author's transl)].
    Frontera Izquierdo P; Unceta Aguirre L; Tomás Vila M; Calvo Rigual F; Pérez Tamarit D
    An Esp Pediatr; 1981 Dec; 15(6):549-52. PubMed ID: 7337308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preajmaline-induced cholestatic hepatitis].
    Pras E; Steinlauf S; Sidi Y
    Harefuah; 1991 Nov; 121(10):380-1. PubMed ID: 1752555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flucloxacillin induced delayed cholestatic hepatitis.
    Miros M; Kerlin P; Walker N; Harris O
    Aust N Z J Med; 1990 Jun; 20(3):251-3. PubMed ID: 2372276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatitis during rifampicin and isoniazid treatment of a patient with generalized tuberculosis].
    Volosevich GV
    Probl Tuberk; 1989; (9):72-3. PubMed ID: 2587561
    [No Abstract]   [Full Text] [Related]  

  • 20. Probable ticlopidine-induced cholestatic hepatitis.
    Cassidy LJ; Schuster BG; Halparin LS
    Ann Pharmacother; 1995 Jan; 29(1):30-2. PubMed ID: 7711343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.